Overcoming Secondary Mutations of Type II Kinase Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overcoming Secondary Mutations of Type II Kinase Inhibitors

Published:2024-06-05 Issue:12 Volume:67 Page:9776-9788
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Xiuqi¹^ORCID,DeFilippis Rosa Anna²,Yan Wei³⁴^ORCID,Shah Neil P.²,Li Hong-yu³⁴^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States

2. Division of Hematology/Oncology, University of California, San Francisco, California 94143, United States

3. Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States

4. Department of Pharmacology, School of Medicine, The University of Texas Health San Antonio, San Antonio, Texas 78229, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c01629

Reference112 articles.

1. Kinetic and Catalytic Mechanisms of Protein Kinases

2. Kinase-targeted cancer therapies: progress, challenges and future directions

3. Structural Basis for Control by Phosphorylation

4. The Protein Kinase Complement of the Human Genome

5. Oncogenic kinase signalling

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP